XML 15 R7.htm IDEA: XBRL DOCUMENT v3.26.1
Unaudited Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash Flows from Operating Activities:    
Net Loss $ (15,805) $ (15,489)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 10,330 12,810
Deferred financing costs amortization 42 43
Stock-based compensation expense 1,383 1,627
Debt discount amortization 236 226
Allowance for credit losses 57 (407)
Gains from equipment sales, retirements or impairments (7,448) (5,809)
Derivative gains 0 (125)
Interest on finance leases 1 1
Settlement on derivative transactions, net 0 (373)
Currency (gains) losses (478) 1,196
Deferred income taxes (482) (1,725)
Equity earnings (50) (889)
Changes in Operating Assets and Liabilities:    
Accounts receivables (5,735) 5,333
Other assets (1,306) (1,681)
Accounts payable and accrued liabilities 4,122 (6,204)
Net cash used in operating activities (15,133) (11,466)
Cash Flows from Investing Activities:    
Purchases of property and equipment (6,088) (20,795)
Proceeds from disposition of property and equipment 12,778 8,472
Net cash provided by (used in) investing activities 6,690 (12,323)
Cash Flows from Financing Activities:    
Payments on long-term debt (7,500) (5,000)
Payments on long-term debt issuance costs 0 (396)
Payments on finance leases (3) (9)
Tax withholdings on restricted stock vesting and director share awards (1,737) (1,518)
Net cash used in financing activities (9,240) (6,923)
Effects of Exchange Rate Changes on Cash, Restricted Cash and Cash Equivalents (1) 0
Net Change in Cash, Restricted Cash and Cash Equivalents (17,684) (30,712)
Cash, Restricted Cash and Cash Equivalents, Beginning of Period 93,116 76,140
Cash, Restricted Cash and Cash Equivalents, End of Period 75,432 45,428
Supplemental disclosures:    
Cash paid for interest, excluding capitalized interest 2,750 10,935
Noncash Investing and Financing Activities:    
Increase (decrease) in capital expenditures in accounts payable and accrued liabilities 348 (5,182)
Recognition of a new right-of-use asset - operating leases $ 83 $ 0